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Abstract. Recurrent episodes of acute adenolymphangitis (ADL) are important clinical manifestations of
lymphatic filariasis which contribute significantly to the progression of lymphedema. It is increasingly
being recognized that secondary bacterial infections play an important role in the etiology of ADL. We
examined the role of streptococcal infection as a precipitating factor of ADL in brugian filariasis, by
determining the anti-streptolysin O (ASO) titers and by isolating the causative organism wherever possible.
The study population consisted of 30 patients with filariasis related ADL (Group A), 30 patients with chronic
filarial edema (Group B) and 60 age and sex matched healthy adults (Group C). ASO titer was estimated
by the latex agglutination method at the time of entry into the study, at the 15th day and at 3,6 and 12 months.
ASO titers were persistently elevated in 90% of patients in Group A and a portal of entry for bacterial
infection was detected in all of these patients. In Group B only six patients had persistently elevated ASO
titers. These patients had grade III lymphedema and three of them had monilial infections in the affected
limb. In the control group none had persistently elevated ASO titers. The elevated ASO titers and the
detection of a site of entry for bacteria in patients with ADL supports a streptococcal etiology for this
condition.
INTRODUCTION
Lymphatic filariasis is a major health problem
with over 1 billion people living in areas endemic
for filariasis and nearly 120 million with various
forms of the disease. India, with over 22 million
microfilaria carriers and 16 million clinical cases
(of whom 6 million suffer from acute manifesta-
tions), has the largest number of cases in the world.
Even though bancroftian filariasis is the most com-
mon form of the disease in India, Brugia malayi
infection is common in parts of Kerala. In Alappuzha
district one such pocket of Brugia malayi exists in
Sherthallai taluk where the estimated prevalence of
lymphatic filariasis was 9.9% of the general popu-
lation (Sabesan et al, 1992).
It has been observed that the chronic forms of
lymphatic filariasis are more common in the lower
socio-economic groups of the population (Pani et
al, 1989; Shenoy et al, 1995). A large proportion of
these patients suffer from repeated and often inca-
Correspondence: Dr RK Shenoy, Filariasis Chemotherapy
Unit, TD Medical College Hospital, Alappuzha 688011,
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pacitating attacks of acute adenolymphangitis
(ADL), characterized by high fever and painful,
tender and reddish swelling of the affected region
and/or the draining lymph nodes.
Attacks of adenolymphangitis are an important
feature of lymphatic filariasis. Although the dis-
ease produces gross deformities it is often only
these episodes of ADL that force patients with
lymphatic filariasis to seek medical attention. Re-
current attacks of ADL also hasten the progression
of ftilarial edema resulting in elephantiasis. Sur-
veys conducted in Pondicherry and Sherthallai es-
timated a frequency of 4.47 ADL episodes per year
forbancroftian filariasis and 2.2 episodes for brugian
filariasis. On an average, such attacks last for four
days, which result in absence from work and thus
economic loss (Pani et al, 1990). In Sherthallai, the
economic loss due to brugian filariasis was esti-
mated to be 1.6 lakhs mandays/year (Sabesan et al,
1992). It is therefore important to prevent and
promptly treat these ADL attacks in patients with
lymphatic filariasis.
It is increasingly being recognized that second-
ary bacterial infections play an important role in the
etiology of acute attacks. We have previously
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shown that ADL attacks in patients with lymphatic
filariasis are precipitated by secondary bacterial
infection which gain entry through broken skin
(Shenoy et al, 1995).
There is growing evidence to suggest that
streptococci are the commonest organisms involved
in the causation of these attacks. Studies in experi-
mental animals (Ewert et al, 1980) and in patients
with lymphatic filariasis (Olszewski and Jamal,
1994; Pani et al, 1995; Olszewski et al, 1997) have
demonstrated these organisms in the skin and lym-
phatic fluid ofpatients with lymphedema. We have
previously shown that 28 out of 65 patients with
lymphatic tilariasis had elevated ASO titers (> 200
IU) and that elevated titers (> 200 IU) were seen in
40% of patients in whom a portal of entry for bac-
teria could be demonstrated (Shenoy et al, 1995).
Other pieces of indirect evidence also point to an
important role for streptococci in the causation of
ADL attacks. For example patients with ADL often
receive oral or parenteral penicillin, the drug of
choice for the management of streptococcal infec-
tions, for the treatment of their ADL attacks.
In the present study we examined the role of
streptococcal infection as a precipitating factor of
acute adenolymphangitis in brugian filariasis, by
determining the ASO titers and by isolating the
causative organism, wherever possible.
MATERIALS AND METHODS
This study was carried out in the Filariasis
Chemotherapy Unit, TD Medical College Hospital,
Alappuzha.
Patient population
The study population consisted of 30 patients
with acute filarial adenolymphangitis, 30 patients
with chronic filarial edema and 60 age and sex
matched normal healthy adults. Thus there were
the following three groups:
Group A: The 30 patients in this group had filariasis
related acute adenolymphangitis (ADL) at the time
of entry into this study. A diagnosis of filariasis
related ADL was made: 1) When an attack of acute
adenolymphangitis was associated with underlying
filarial edema or 2) When there was a history of at
least 2 ADL attacks in the past year, in the absence
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of filarial edema.
Group B: The 30 patients in this group had chronic
lymphatic filariasis without any ADL episode dur-
ing the previous six months.
Group C: 60 age and sex matched normal healthy
adults.
Study design
All subjects enrolled in the study underwent a
detailed clinical examination. In patients belong-
ing to groups A and B, the lymphedema was graded
as follows:
Grade 1. Mostly pitting edema reversible on eleva-
tion of the affected limb.
Grade II: Mostly non-pitting edema, not reversible
on elevation of the affected limb.
Grade III: Mostly non-pitting edema with
dermatosclerosis and warty excrescences.
In these patients a diligent search was made for
any evidence of discontinuity in the skin either in
the form oftrivial injuries, fungal infections or any
similar cause. Laboratory investigations such as
complete hemogram, urinalysis and serum chemis-
try were carried out in all the subjects enrolled in
the study. Anti-streptolysin O (ASO) titers were
estimated by latex agglutination method. All sam-
ples were tested using the ASO (Latex) test kits
supplied by Avon laboratories. These kits were
used to estimate ASO levels in a semiquantitative
fashion using a suspension of polystyrene latex
particles coated with stabilized Streptolysin O.
Positive and negative controls were used in each
batch. In patients belonging to group A swabs from
sites of infection for isolation of streptococci were
taken wherever indicated.
All patients were asked to report to the clinic
whenever they had an acute attack and these were
confirmed by the physician in charge of the study.
Each attack was treated using a combination of
antibiotics and anti-inflammatory agents.
All study subjects were followed up on the 15th
day, 3rd month, 6th month and at the end of one
year. ASO titers were estimated in all patients at the
time of the admission to the study and at all the
follow up points. Cultures from the sites of infec-
tion were repeated where indicated.
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RESULTS
The age and sex distribution along with the
grades of edema in the three groups are given in
Table 1.
monilial infection in the affected limb. Among the
60 age and sex matched controls in group C, the
ASO was negative in 57 and was only transiently
elevated in three.
Table 1
DISCUSSION
Age, sex distribution of edema grades.
Groups A(30) B(30) C(60)
Mean Age
Males
Females
Edema Gr I
Edema Gr II
Edema Gr III
39 40 38
20 17 37
10 13 23
5 1 0
4 17 0
21 12 0
There were 20 males and 10 females in group A.
The age group ranged from 20-56 years (mean 39
years). In 21 patients there was grade III edema,
whereas in 4 it was grade II and grade I in the
remaining 5 patients.
The ASO titer was positive throughout the
study in 27 out of 30 patients belonging to Group A
and in all of them there was a local source of in-
fection in the affected limb in the form of monilial
infection in the interdigital webs in 14 and minor
injuries in 14, out of whom two patients had both
monilial infection and minor injury in the affected
limb. One other patient had infected eczema.
Even though ADL attacks in lymphatic filariasis
have been extensively studied, their pathogenesis is
not well understood. Earlier postulates favored
parasitic causes such as mechanical irritation caused
by the movement of the adult parasite inside the
lymphatics, inflammation induced by moulting fluid
or toxic products from the dead parasite (Ottesen,
1980). There is now mounting evidence to suggest
that secondary bacterial infection is the most im-
portant factor in the pathogenesis of ADL in
filariasis. It has been observed that injuries (often
trivial), fungal infections and loss of epithelium
due to similar causes predispose to bacterial infec-
tions, especially by streptococci, resulting in ADL.
Local dissemination of streptococcal infection is
through lymphatics producing rapidly spreading
lymphangitis and lymph node enlargement. Recur-
rent ADL occurs commonly in higher grades of
lymphedema and elevated ASO titers are also seen
more frequently in this group (Shenoy et al, 1995).
Even though swabs for bacteriology were taken
from all patients who had a local source of infec-
tion, only in 8 the culture was positive. Streptococci
were grown in 2, Staphylococcus aureus in 4 while
there was mixed growth in two specimens.
In group B patients there were 17 males and 13
females and their ages ranged from 18-59 years
(mean 40 years). The lymphedema was grade I in
one patient, grade II in 17 and Grade III in remain-
ing 12 patients.
Streptococci are known to produce different
exoenzymes, one of which is Streptolysin O. Anti-
bodies to this exoenzyme (ASO) are positive in 80-
85% of patients infected with streptococci (Klein,
1980). Measurement of ASO antibodies in the
human sera has been proved to be exceedingly
useful as an indicator of recent streptococcal infec-
tion and are easily measured by quantitative labora-
tory tests (Gray et al, 1994). The latex agglutina-
tion assay used in the present study has been shown
to have a sensitivity of 91%, specificity of 86%,
positive predictive value of 83% and negative pre-
dictive value of 92% (Gerber et al, 1990). Rise in
ASO titer begins about one week after the infection
and peaks 2-4 weeks later. In the absence of
complications or reinfection ASO titers return to
normal levels in 6 to 12 months.
In this group of 30 patients with chronic filarial In the present study an attempt was made to
edema ASO was negative in 20 patients. While six assess the relation between streptococcal infection
had ASO titers raised throughout the study period, and the ADL episodes of lymphatic filariasis. Dur-
there was only a transient rise in the remaining four. ing the one year study period persistently elevated
The six patients with persistently elevated ASO ASO titers were noticed in 27 out of 30 patients
titers had grade III edema and three of them had (90%) with ADL in group A who also experienced
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recurrent ADL attacks during the study period. It
is also significant that in all the 27 patients with
elevated ASO titers in the ADL group, a portal of
entry for secondary infection was present in the
affected limb.
In group B consisting of patients with chronic
filarial edema without any recent ADL, persistent
rise in ASO titer was seen only in 20% and in the
control group C, none of the subjects had persistent
elevation of ASO titers. A local source was also
seen in 50% ofpatients with persistent elevation of
ASO titers in the chronic lymphedema group.
Even though persistent rise in ASO titers was
seen in all grades of edema in the ADL group A,
significantly it was observed only in cases with
grade III edema in the chronic lymphedema group.
While moniliasis is the predisposing cause in higher
grades of edema, minor injuries top the list in
grades I and II edema. In limbs with elephantiasis
the toes are closely apposed and presence of mois-
ture in the interdigital webs predisposes to fungal
infections. The resulting injury to the skin favors
entry of secondary pathogens.
We have previously shown that in lymphedema-
tous limbs injuries, often trivial, fungal infections
or loss of epithelium due to any cause predispose to
ADL (Shenoy et al, 1995). It is this local loss of
integrity of the skin that aids the entry ofpathogens
into the lymphatics. In the present study we have
demonstrated a positive relation between the pres-
ence of a portal of entry for bacteria in the affected
limb and elevated ASO titers. Since elevated ASO
titers are associated with recent strepotococcal in-
fection, the persistent elevation noticed in 90% of
cases with ADL in group A indirectly suggests that
streptococcal infection was a precipitating factor
for these ADL episodes.
An attempt was made in this study to isolate the
pathogens responsible for the ADL attacks by tak-
ing swabs from any wet lesion present in the af-
fected limb from patients in group A. In 8 out of
the 30 patients bacteria were isolated; streptococci
in 2, staphylococci in 4 and mixed growth in 2.
The delay between collection of the swabs and
delivery at the laboratory necessitated by the dis-
tance involved might be responsible for the low
positivity.
The persistently elevated ASO titers in patients
with recurrent ADL favor a streptococcal etiology
for the ADL of lymphatic filariasis. These ob-
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servations are important in the management of
filarial edema, prevention of further ADL episodes
and thus arresting the progression of the disease.
This study like other recent ones (Shenoy et al,
1995; Olszewski et al, 1997), also convincingly
demonstrates additional proof of the role of bacte-
rial infection in the causation of ADL. These
findings have important implications for the pre-
vention and treatment of acute ADL episodes. Lo-
cal care of the lymphedematous limb combined
with local application of antibiotic or antifungal
creams and long term antibiotic therapy assume
significance in the light of the findings of this
study. Lastly we believe that this study, by demon-
strating that streptococci are the main organisms
involved provides useful information on the choice
of antibiotics in the management of ADL attacks.
Controlled clinical trials which explore these issues
are clearly required to define the prevention and
management of ADL attacks associated with lym-
phatic filariasis.
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